Tobramycin 40 MG/ML Injectable Solution

Known as: TOBRAMYCIN SULFATE 40 mg in 1 mL INTRAVENOUS INJECTION [Tobramycin Sulfate], TOBRAMYCIN SO4 1.2GM/VIL INJ [VA Product], Tobramycin sulfate 40 MILLIGRAM In 1 MILLILITER INTRAMUSCULAR INJECTION [Tobramycin] 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2017
01219822017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND Tobramycin is frequently used for treatment of bronchopneumonia in patients with cystic fibrosis (CF). Variability in… (More)
Is this relevant?
2017
2017
Pseudomonas aeruginosa is an opportunistic multidrug resistant pathogen causing severe chronic infections. Our previous studies… (More)
Is this relevant?
2015
2015
The objective of this study was to develop a functionally enhanced antibiotic that would improve the therapeutic activity against… (More)
Is this relevant?
Review
2011
Review
2011
STUDY OBJECTIVES To compare the pharmacokinetics (PK) of tobramycin in patients with cystic fibrosis (CF) before and after… (More)
  • table 2
Is this relevant?
2005
2005
BACKGROUND Cystic fibrosis (CF) is characterized by chronic pulmonary infection with acute pulmonary exacerbations (APEs… (More)
Is this relevant?
1995
1995
The combined use of antibiotics with low levels of electrical current has been reported to be more effective in controlling… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
1982
1982
The suppressive effect of amikacin, gentamicin, tobramycin and paromomycin on the aerobic endogenous flora and on the… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
Is this relevant?